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In a previous report, we showed that proteolytic processing of an 87-kDa mature viral protein from the coronavirus
infectious bronchitis virus (IBV) 1a and 1a/1b polyproteins was mediated by two putative overlapping papain-like proteinase
domains (PLPDs) encoded within the region from nucleotides 4243 to 5553 of ORF 1a (Liu et al., 1995). In this study, we
demonstrate that only the first domain, PLPD-1, is responsible for this cleavage, as deletion of the second domain did not
affect the formation of the 87-kDa protein. Site-directed mutagenesis studies further showed that a previously predicted
nucleophilic cysteine residue (Cys1274) and a histidine residue (His1437) were essential for the proteinase activity, indicating
that they may be important components of the catalytic center of the proteinase. Meanwhile, expression of a series of
deletion mutants revealed that the 87-kDa protein was encoded by the 59-most 2.6 kb of ORF 1a. Deletion and amino acid
substitution mutation studies demonstrated that the Gly673–Gly674 dipeptide bond was most likely the cleavage site
responsible for releasing the C-terminus of the 87-kDa protein from the 1a and 1a/1b polyproteins. © 1998 Academic Press
INTRODUCTION
Avian infectious bronchitis virus (IBV) is the proto-
type of Coronaviridae, a family of enveloped viruses
which possess a large continuous positive-stranded
RNA genome. The genomic RNA is 27.6 kb in length
and contains at least 10 distinct open reading frames
(ORFs) (Boursnell et al., 1987). Most of these ORFs do
not appear to be translated from the genomic RNA but
are expressed from a set of subgenomic mRNAs. Six
mRNA species, including a genome-length mRNA
(mRNA 1) and five subgenomic mRNA species (mRNA
2-6), are produced in virus-infected cells. These mR-
NAs range in length from about 2 to 27.6 kb and have
been shown to form a 39-coterminal ‘‘nested’’ structure
(Stern and Sefton, 1984).
Approximately 70% of the coding potential of the IBV
genome is contained within the 59-terminal unique re-
gion of mRNA 1. Nucleotide sequencing has shown that
mRNA 1 contains two large overlapping ORFs (1a and
1b), with ORF 1a having the potential to encode a
polyprotein of 441 kDa and 1b a polyprotein of 300 kDa
(Boursnell et al., 1987). The downstream ORF 1b is pro-
duced as a fusion protein of 741 kDa with 1a by a
ribosomal frameshifting mechanism (Brierley et al., 1987,
1989). These polyproteins are expected to be cleaved by
viral or cellular proteinases to produce functional prod-
ucts associated with viral replication.
Recently, products encoded by these two ORFs have
been identified. These include 87-, 10-, and 100-kDa
polypeptides (Liu et al., 1994, 1995, 1997; Liu and Brown,
1995). Three ORF 1a-encoding proteinase domains, i.e.,
two overlapping papain-like proteinase domains (PLPDs)
encoded by the IBV sequence between nucleotides 4243
and 5553 and a picornavirus 3C-like proteinase domain
encoded between nucleotides 8937 and 9357, were dem-
onstrated to be involved in the production of these ma-
ture viral proteins (Liu et al., 1994, 1995, 1997; Liu and
Brown, 1995). Proteolytic processing of the 1a and 1a/1b
polyproteins by the equivalent proteinase activities of
human coronavirus and mouse hepatitis virus has also
been documented. So far, four mature products have
been identified in cells infected by human coronavirus
strain 229E. These include a 34-kDa protein representing
the 3C-like proteinase, a 105-kDa protein corresponding
to the 100-kDa protein of IBV, a 71-kDa protein with an
ATPase activity, and a 41-kDa protein processed from the
1b polyprotein (Ziebuhr et al., 1995; Grotzinger et al.,
1996; Heusipp et al., 1997a, b). Similarly, three mature
products, including two N-terminal cleavage products of
28 and 65 kDa and a 27-kDa protein identified as the
3C-like proteinase, have been reported for mouse hep-
atitis virus (Denison and Perlman, 1987; Denison et al.,
1995; Lu et al., 1995).
In this communication, we report that of the two pre-
dicted PLPDs of IBV, only the first one, PLPD-1, encoded
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between nucleotides 4243 and 5019, is required for
cleavage of the 87-kDa protein at its C-terminus. Site-
directed mutagenesis studies confirmed that the previ-
ously predicted Cys1274 and His1437 residues of PLPD-1
are essential for the proteinase activity, suggesting that
they may be components of the catalytic center of the
proteinase. Meanwhile, expression of a series of C-
terminal deletion mutants indicated that the Gly673–Gly674
dipeptide bond encoded by nucleotides 2545 to 2550
may be responsible for releasing the C-terminus of the
87-kDa protein. Site-directed mutagenesis and internal
deletion studies further demonstrated that this dipeptide
bond was indeed the C-terminal cleavage site of the
87-kDa protein. As no further N-terminal cleavage of the
1a polyprotein was observed, it is therefore established
that the 87-kDa protein is encoded by the ORF 1a se-
quence between nucleotides 529 and 2547.
RESULTS
Further analysis of processing of the 1a and 1a/1b
polyproteins to an 87-kDa protein by the two
overlapping papain-like proteinase domains
We have previously demonstrated that expression of
the IBV sequence from nucleotides 362 to 5753
(pIBV1a2) led to the detection of three protein species: a
250-kDa product representing the full-length product of
the construct and two cleavage products of 160 and 87
kDa, respectively (Liu et al., 1995). However, when the
IBV sequence from nucleotides 362 to 4858 (pIBV1a1)
was expressed, no processing of the full-length 220-kDa
protein to smaller products was observed (Liu et al.,
1995). These results suggest strongly that the two puta-
tive overlapping papain-like proteinase domains are in-
volved in processing of the 1a and 1a/1b polyproteins to
the 87-kDa protein species. To further characterize the
proteinase activity and to determine the cleavage sites of
the 87-kDa protein, a series of N-terminal, internal, and
C-terminal deletion mutants were constructed based on
pIBV1a2. Plasmid pIBV1a2D1 contains an N-terminal de-
letion of the IBV sequence from nucleotides 362 to 1310;
pIBV1a2D3 and pIBV1a2D4 contain internal deletions of
the IBV sequences from nucleotides 2251 to 3832 and
from 3047 to 3997, respectively; pIBV1a2D5 contains a
C-terminal deletion of the IBV sequence from nucleotides
5027 to 5753 (see Figs. 1 and 2a). These constructs were
then expressed in Vero cells using the vaccinia virus-T7
expression system (Fuerst et al., 1986).
The N-terminal deletion construct pIBV1a2D1 was
firstly expressed in Vero cells. As can be seen, expres-
sion of pIBV1a2 resulted in the detection, once again,
of the 250-, 160-, and 87-kDa protein species (Fig. 2b).
Similarly, three protein species of approximately 220,
160, and 58 kDa were detected from lysates prepared
from pIBV1a2D1-transfected cells by immunoprecipi-
tation with region-specific antiserum V59 (Fig. 2b). The
220-kDa species is probably the full-length product,
while the 160- and 58-kDa protein species may repre-
sent products derived from a cleavage event. As the
160-kDa protein comigrated with the 160-kDa protein
FIG. 1. Diagram of the structure of plasmid pIBV1a2, showing the locations of the 87-kDa protein, the two putative overlapping papain-like
proteinase domains (PLPDs), and the restriction sites used in this study. The C-terminal cleavage site (Gly6732Gly674 dipeptide) of the 87-kDa protein,
the catalytic residues of the PLPD-1 (Cys1274 and His1437), and the IBV sequence recognized by antiserum V59 are indicated. Also shown are the IBV
sequences present in plasmids pIBV1a1, pIBV1a2D1, pIBV1a2D3, pIBV1a2D4, pIBV1a2D5, pIBV1a2D8, pIBV1a2D9, pIBV1a2D10, pIBV1a2D11,
pIBV1a2D12, and pIBV1a2D14.
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detected from pIBV1a2-transfected cells (Fig. 2b), this
result suggests that it may represent the C-terminal
cleavage product of the 220-kDa protein, and the 58-
kDa protein may be an N-terminally truncated version
of the 87-kDa protein.
In a previous study, we speculated that the 160-kDa
species may be an intermediate cleavage product con-
taining the 87-kDa protein, as both the 87- and 160-kDa
proteins can be immunoprecipitated by the two N-termi-
nal-specific antisera (V52 and V59) used (Liu et al., 1995).
It was therefore likely that a second cleavage site may be
located between the regions coding for the 87-kDa pro-
tein and the two PLPDs. To investigate this possibility,
plasmid pIBV1a2D3 was constructed and expressed. As
can be seen, only the full-length protein of approximately
136 kDa was immunoprecipitated (Fig. 2b). No cleavage
products were detected from the expression of this con-
struct. This result hence rules out the possibility that the
160-kDa is an intermediate cleavage product covering
the 87-kDa protein and a protein of 70 kDa (Fig. 2b). The
reason for the coimmunoprecipitation of the 160-kDa by
antiserum V59 is considered under Discussion.
Plasmid pIBV1a2D4 was next expressed to test the
effect of internal deletion of the region between the
sequences coding for the 87-kDa protein and PLPDs on
processing to the 87-kDa protein. As shown in Fig. 2b,
FIG. 2. (a) Diagram showing the full-length and cleavage products synthesized from plasmids pIBV1a2, pIBV1a2D1, pIBV1a2D3, pIBV1a2D4, and
pIBV1a2D5. (b) Analysis of transiently expressed ORF 1a products from cells transfected with pIBV1a2, pIBV1a2D1, pIBV1a2D3, pIBV1a2D4, and
pIBV1a2D5. Plasmid DNA was transiently expressed in Vero cells using the vaccinia virus/T7 expression system. Cells were labeled with
[35S]methionine, lysates were prepared, and polypeptides were either analyzed directly or immunoprecipitated with antiserum V59. Gel electrophore-
sis was performed on an SDS–10% polyacrylamide gel and polypeptides were detected by fluorography. HMW, high-molecular-mass markers
(numbers indicate kilodaltons).
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expression of pIBV1a2D4 led to the detection of three
products of approximately 190, 100, and 87 kDa. Both the
190- and 87-kDa protein species were efficiently immu-
noprecipitated by antiserum V59; only weak immunopre-
cipitation of the 100-kDa protein, however, was observed
(Fig. 2b). This result demonstrates that the IBV sequence
between nucleotides 3047 and 3997 is not essential for
processing to the 87-kDa protein species and suggests
that the C-terminal cleavage site of the 87-kDa protein is
encoded between nucleotides 2251 and 3047.
Finally, the C-terminal cleavage construct pIBV1a2D5
was expressed to investigate if both of the two putative
PLPDs were required for processing to the 87-kDa pro-
tein. As can be seen, expression of this construct led to
the detection of three protein species of approximately
225, 135, and 87 kDa, respectively (Fig. 2b). Both the 225-
and 87-kDa proteins were efficiently immunoprecipitated
by antiserum V59 (Fig. 2b). This result indicates that
PLPD-1 is responsible for releasing the 87-kDa protein.
In addition to the protein species described above,
expression of pIBV1a2, pIBV1a2D3, pIBV1a2D4, and
pIBV1a2D5 also resulted in the detection of protein spe-
cies which migrated more slowly on SDS–PAGE than
their respective full-length products (Fig. 2b). Further-
more, protein species that migrated between the cleav-
age products were also observed (Fig. 2b). The identities
of these products are currently uncertain, but they may
represent modified forms of the cleavage and full-length
products.
The polypeptides detected from the expression of
pIBV1a2, pIBV1a2D1, pIBV1a2D3, pIBV1a2D4, and
pIBV1a2D5 are illustrated in Fig. 2a.
Mutagenesis studies of the putative catalytic center
of PLPD-1
Data presented above showed that only the first of the
two overlapping proteinase domains was required for
processing to the 87-kDa product. Computer analysis of
the proteinase domain suggested that it may belong to
the papain-like class of thiol proteinase with a catalytic
dyad of cysteine and histidine residues (Gorbalenya et
al., 1989, 1991). In fact, the Cys1274 and His1437 residues
were predicted to be the catalytic dyad of the proteinase
(Lee et al., 1991) (see Fig. 1). To test this prediction,
site-directed mutagenesis was carried out using
pIBV1a2D4 as the template. By monitoring the production
of the 87-kDa protein, the effect of the mutations on the
proteinase activity could be tested.
The putative nucleophilic cysteine (Cys1274) residue,
which was encoded by nucleotides 4348 to 4350, was
first mutated to a Ser residue, giving rise to the mutant
construct pIBV1a2D4C1274-S. As shown in Fig. 3, expres-
sion of pIBV1a2D4, once again, yielded the 190-kDa
full-length product and the 87-kDa protein species. Ex-
pression of pIBV1a2D4C1274-S, however, resulted in the
detection of only the 190-kDa full-length product. No
87-kDa protein was detected, indicating that this substi-
tution disrupts the proteinase activity required for the
release of the 87-kDa protein. Similarly, mutation of the
predicted His1437 residue (encoded by nucleotides 4837
to 4839) to a Lys was introduced, giving rise to
pIBV1a2D4H1437-K. The mutant construct was then ex-
pressed in Vero cells. As can be seen, only the 190-kDa
full-length product was immunoprecipitated by anti-
serum V59; no 87-kDa protein was detected (Fig. 3).
These results support the computer prediction that both
the Cys1274 and His1437 are essential for the catalytic
activity of the proteinase.
Deletion analysis of the C-terminal cleavage site of
the 87-kDa protein
Data obtained from the expression of pIBV1a2D3 and
pIBV1a2D4 indicate that the C-terminal cleavage site of
the 87-kDa protein is encoded between nucleotides 2251
and 3047. To define more precisely the cleavage site, a
series of C-terminal deletion mutants were constructed
by introducing a termination codon (UAA) into different
positions of the IBV sequence (see Fig. 1). By comparing
the migration of products expressed from the mutant
FIG. 3. Mutational analysis of the two putative catalytic residues
(Cys1274 and His1437) of PLPD-1. Vero cells were transfected with plas-
mids pIBV1a2D4, pIBV1a2D4C1274-S, and pIBV1a2D4H1437-K and la-
beled with [35S]methionine and lysates were prepared. Polypeptides
were either analyzed directly or immunoprecipitated with antiserum
V59. Gel electrophoresis was performed on an SDS–10% polyacryl-
amide gel and polypeptides were detected by fluorography. HMW,
high-molecular-mass markers (numbers indicate kilodaltons).
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constructs with the 87-kDa protein processed from the
wild-type plasmids, it would allow us to locate more
precisely the C-terminal cleavage site of the 87-kDa
protein.
The first of such mutants, pIBV1a2D8, was made by
introducing a UAA codon at the nucleotide position 2854.
Expression of this plasmid led to the synthesis of a
product migrating on SDS–PAGE more slowly than the
87-kDa protein expressed from pIBV1a2D4 (Fig. 4a). The
apparent molecular mass of this protein is approximately
98 kDa, indicating that the actual cleavage site is located
at least 250 bp upstream of this position. However, this
interpretation was based on the assumption that the
87-kDa protein was encoded by the 59-most part of ORF
1a and no N-terminal cleavage of the 1a polyprotein
occurred before the 87-kDa protein.
To avoid this ambiguity, four deletion mutants,
pIBV1a2D9, pIBV1a2D10, pIBV1a2D11, and pIBV1a2D12,
were constructed based on pIBV1a2D1 by inserting the
UAA triplet at nucleotide positions 2854, 2599, 2545, and
2515, respectively (see Fig. 1). Expression of pIBV1a2D9
and pIBV1a2D10 led to the detection of two protein species
migrating more slowly on SDS–PAGE than the 58-kDa pro-
tein expressed from pIBV1a2D1. Their apparent molecular
masses are approximately 65 and 62 kDa, respectively (Fig.
4b). Expression of pIBV1a2D11 led to the detection of a
protein species which almost comigrates with the 58-kDa
expressed from pIBV1a2D1 on SDS–PAGE (Fig. 4b). Expres-
sion of pIBV1a2D12, however, resulted in the detection of a
product with an apparent molecular mass of approximately
56 kDa (Fig. 4b). These results indicate that the C-terminal
cleavage site of the 87-kDa protein is in the vicinity of amino
acid residue Gly673 encoded between nucleotides 2545
and 2547.
Further determination of the C-terminal cleavage site
of the 87-kDa protein by site-directed mutagenesis
and deletion analysis
From the observation that the C-terminus of the 87-
kDa protein is probably located near nucleotide position
2550, it is tempting to speculate that this protein may be
cleaved from the precursor at a potential Gly673–Gly674 or
Thr676–Val677 dipeptide bond. By comparative analysis of
the cleavage sites used by other viral papain-like pro-
teinases, it seems likely that either of the two sites could
be the scissile bond of PLPD-1 (Bonilla et al., 1995, 1997;
Dong and Baker, 1994; Hughes et al., 1995). To explore
these possibilities, substitution mutations of the Gly673
residue with an Ala and the Thr676 residue with a Ser
were made, giving rise to the mutant constructs
pIBV1a2D4G673-A and pIBV1a2D4T676-S. As can be seen,
expression of pIBV1a2D4G673-A led to the detection of
the full-length 190-kDa protein; no processing to the
FIG. 4. Deletion analysis of the C-terminal cleavage site of the 87-kDa protein. Plasmids pIBV1a2D4 and pIBV1a2D8 (a) and plasmids pIBV1a2D1,
pIBV1a2D9, pIBV1a2D10, pIBV1a2D11, and pIBV1a2D12 (b) were transiently expressed in Vero cells using the vaccinia virus/T7 expression system.
Cells were labeled with [35S]methionine and lysates were prepared. Polypeptides were either analyzed directly or immunoprecipitated with antiserum
V59. Gel electrophoresis was performed on an SDS–10% polyacrylamide gel and polypeptides were detected by fluorography. Control DNA indicates
that a plasmid not containing the IBV sequence was used. HMW, high-molecular-mass markers (numbers indicate kilodaltons).
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87-kDa protein was observed (Fig. 5). However, both the
190- and 87-kDa proteins were observed when
pIBV1a2D4T676-S was expressed (Fig. 5). Furthermore,
the relative amount of the 87-kDa protein to the 190-kDa
protein expressed from this mutant construct was very
similar to that expressed from the wild-type construct
pIBV1a2D4 (Fig. 5), indicating that the production of the
87-kDa protein was not affected by mutation of the Thr676
to a Ser residue. These results suggest strongly that the
Gly673–Gly674 dipeptide bond is the C-terminal cleavage
site of the 87-kDa protein.
To support this conclusion further, the six nucleotides
coding for the Gly673–Gly674 scissile bond were deleted by
PCR, giving rise to plasmid pIBV1a2D4DG673–G674. As can
be seen, expression of pIBV1a2D4DG673–G674 resulted in
the detection of the 190-kDa full-length product only. No
87-kDa protein was detected (Fig. 5), confirming that dele-
tion of the Gly673–Gly674 dipeptide bond totally blocks the
release of the 87-kDa protein from its precursor.
No N-terminal cleavage of the 1a polyprotein before
the 87-kDa protein
To rule out the possibility that further N-terminal cleav-
age is required for releasing the 87-kDa protein from the
1a and 1a/1b polyprotein precursors, plasmid
pIBV1a2D14 was made by extending the 59 end of
pIBV1a2D11 to cover the IBV sequence up to nucleotide
362 and was expressed in Vero cells. The mobility of the
full-length product expressed from this plasmid was then
compared with the 87-kDa protein processed from
pIBV1a2D4. As expected, expression of pIBV1a2D14 re-
sulted in the synthesis of a protein which comigrates on
SDS–PAGE with the 87-kDa protein expressed from
pIBV1a2D4 (data not shown). This result indicates that no
N-terminal cleavage of the 1a polyprotein occurs before
the 87-kDa protein.
Throughout this and our previous report (Liu et al.,
1995), this protein was referred to as 87 kDa based
purely on its migration on linear SDS–PAGE. In an early
communication, Brierley et al., (1990) noted that Western
blots of IBV-infected chicken kidney cells and Vero cells
with antiserum V59 led to the detection of a virus-specific
polypeptide of 75 kDa. This 75-kDa protein was subse-
quently shown to migrate on linear SDS–PAGE at the
same position as the 87-kDa product (Liu et al., 1995). It
is likely that the gradient SDS–PAGE system used in the
original report may reflect more accurately the real mo-
lecular mass of the protein. To test this possibility, ly-
sates prepared from pIBV1a2D4- and pIBV1a2D14-trans-
fected cells were immunoprecipitated with antiserum
V59 and separated on an SDS–7.5 to 15% polyacrylamide
gradient gel. Once again, comigration of the 87-kDa
protein expressed from both plasmids was observed
(Fig. 6). It was also noted that the 87-kDa protein and the
full-length product migrated slightly more rapidly in this
gel system; the estimated molecular masses are approx-
imately 78 and 180 kDa, respectively. Obviously, the mi-
gration of the 87-kDa protein in this gel system is closer
to its calculated molecular mass of 75 kDa.
DISCUSSION
Co- and posttranslational processing of polyproteins
encoded by the 27.6-kb genome-length mRNA, mRNA 1,
of the coronavirus IBV is an essential step in the viral
replication cycle. Three viral proteinase domains, i.e.,
two overlapping PLPDs and a picornavirus 3C-like pro-
teinase domain, have been predicted to be involved in
these processing events (Gorbalenya et al., 1989, 1991;
Lee et al., 1991). PLPD-1, the so-called ‘‘main’’ proteinase,
is encoded by ORF 1a from nucleotides 4243 to 5019 and
located downstream of the ‘‘X’’ domain (Lee et al., 1991;
Gorbalenya et al., 1991). The second PLPD, which shares
similarity with the streptococcus proteinase, is encoded
by nucleotides 4681 to 5553 (Gorbalenya et al., 1989,
1991). In a previous communication, we reported that the
region coding for the two putative PLPDs was required
for processing of the 1a and 1a/1b polyproteins to an
87-kDa mature viral product (Liu et al., 1995). Evidence
presented in this report demonstrates that only PLPD-1
FIG. 5. Mutational and deletion analyses of the C-terminal cleavage
site of the 87-kDa protein. Plasmids pIBV1a2D4, pIBV1a2D4G673-A,
pIBV1a2D4T676-S, and pIBV1a2D4G673-G674 were transiently expressed
in Vero cells using the vaccinia virus/T7 expression system. Cells were
labeled with [35S]methionine and lysates were prepared. Polypeptides
were immunoprecipitated with antiserum V59. Gel electrophoresis was
performed on an SDS–10% polyacrylamide gel and polypeptides were
detected by fluorography. Numbers indicate molecular masses in kilo-
daltons.
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is responsible for cleavage of the 87-kDa protein from its
polyprotein precursors. This conclusion is supported by
two observations. Firstly, production of similar amount of
the 87-kDa protein was observed from expression of
constructs with or without the second proteinase do-
main. Second, mutation of the two predicted catalytic
residues of PLPD-1, the Cys1274 and His1437, totally abol-
ished the proteinase activity required for processing to
the 87-kDa protein. As the second PLPD is still present in
these mutants, this result reinforces the conclusion that
only PLPD-1 is required for cleavage of the 1a and 1a/1b
polyproteins to the 87-kDa protein species.
The observation that the PLPD-1 activity is inactivated
by substitution mutations of the Cys1274 and His1437 con-
firms that they are most likely the catalytic residues of
the proteinase. However, when the IBV sequence up to
nucleotide 4858 (and therefore includes these two core
residues) was expressed, no proteinase activity was
detected (Liu et al., 1995), indicating that besides the
catalytic center of the enzyme, the region from nucleo-
tides 4859 to 5027 is also indispensable for the activity of
the proteinase. The significance of this region in the
formation of the catalytic center, substrate binding, and
overall folding of the proteinase remains to be under-
stood. As for the second PLPD, no functional role has
been reported so far. This lack of activity hampers its
further characterization by mutagenesis study. In fact, no
proteinase activity has been documented for the second
PLPD of human coronavirus and mouse hepatitis virus
strains JHM and A59 (Baker et al., 1993; Bonilla et al.,
1995, 1997; Dong and Baker, 1994; Hughes et al., 1995;
Herold et al., 1998). It is likely that the second PLPD of
coronavirus may be functionally inactive.
Deletion and mutagenesis studies demonstrated con-
vincingly that cleavage of the C-terminus of the 87-kDa
protein may occur between the Gly673–Gly674 dipeptide
bond. Examination of cleavage sites recognized by other
viral papain-like proteinases suggested that they may
consist of two small amino acids with short, uncharged
side chains; in most cases, the P1 site is a Gly residue
and the P19 a Gly, an Ala, or a Val (Bonilla et al., 1997;
Dong and Baker, 1994). According to these criteria, the
Thr676–Val677 dipeptide bond encoded by nucleotides
2554 to 2559 may also be a cleavage site of PLPD-1.
However, as shown in Fig. 5, mutation of the Thr676
residue to a Ser did not affect processing to the 87-kDa
protein. Another potential cleavage position is the
Gly680–Glu681 dipeptide bond encoded by nucleotides
2566 to 2571. This possibility is ruled out by deletion of
the Gly673–Gly674 dipeptide bond, which totally abolished
the release of the 87-kDa protein (Fig. 5). As these two
residues are located six and seven amino acids, respec-
tively, upstream of the Gly680, this deletion should render
very little, if any, effect on the cleavability of the Gly680–
Glu681 dipeptide bond if it were a genuine cleavage site.
These results virtually exclude the possibilities that ei-
ther the Thr676–Val677 or Gly680–Glu681 dipeptide bond is
the C-terminal cleavage site of the 87-kDa protein. Mean-
while, deletion studies also suggested that no N-terminal
cleavage was required for releasing the 87-kDa protein
from the 1a and 1a/1b polyproteins, indicating that it is
encoded by ORF 1a from the authentic AUG initiation
codon at nucleotide positions 529 to 531. Therefore, the
87-kDa protein is released from its polyprotein precur-
sors via a single cleavage mediated by PLPD-1 at the
Gly673–Gly674 scissile bond; it is composed of 673 amino
acid residues with a calculated molecular mass of 75
kDa. The reason for the increased apparent molecular
masses of this protein (as well as the full-length product
encoded by the first 5753 bp of ORF 1a) on SDS–PAGE is
uncertain, but it may reflect the amino acid composition
of the products encoded by this region. Examination of
the deduced amino acid sequence shows that the region
between nucleotides 2300 and 3800 encodes a product
with unusually high content of negatively charged amino
acid residues (21.8%). This may influence the mobility of
the products on SDS–PAGE. To support this view, it was
observed that deletion of this region resulted in synthe-
sis of the full-length protein with an electrophoretic mo-
bility on SDS–PAGE consistent with its calculated molec-
ular mass (Fig. 2, lane pIBV1a2D3). As no functional
FIG. 6. Analysis of the migration in gradient SDS–PAGE of the 87-kDa
protein transiently expressed from pIBV1a2D4 and pIBV1a2D14. Vero
cells were transfected with plasmid DNAs and labeled with [35S]me-
thionine and lysates were prepared. Polypeptides were immunopre-
cipitated with antiserum V59. Gel electrophoresis was performed on an
SDS–7.5–15% polyacrylamide gel and polypeptides were detected by
fluorography. HMW, high-molecular-mass markers (numbers indicate
kilodaltons).
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domain has been allocated to this region of the genome
yet, the significance of such a high proportion of nega-
tively charged amino acid composition remains unclear.
In summary, data presented here and in our previous
communication demonstrate that IBV PLPD-1 resembles
the first PLPD of human coronavirus 229E and mouse
hepatitis virus strains JHM and A59 in terms of the
composition of the catalytic residues and the cleavage
specificity (Baker et al., 1993; Bonilla et al., 1995, 1997;
Dong and Baker, 1994; Hughes et al., 1995; Herold et al.,
1998). However, three major differences were also ob-
served. First, IBV PLPD-1 exhibits no proteinase activity
in cell-free expression systems. Extensive investigation
showed that expression of ORF 1a up to nucleotide 5753
in rabbit reticulocyte lysate (Liu et al., 1995) led to the
detection of only the full-length product and several prod-
ucts derived from premature termination of translation.
No cleavage of the full-length product to the 87-kDa
protein was observed. Interestingly, no proteinase activ-
ity could be detected when the IBV 3C-like proteinase
was expressed in cell-free expression systems (Liu et al.,
1994). Second, although the general recognition pattern
of the three coronavirus PLPD described so far is similar,
IBV PLPD-1 shows unique features. The most notable
difference of the IBV PLPD-1 recognition site is in the P5
position. Instead of a basic amino acid, a Val residue
was located at this position. This indicates that IBV
PLPD-1 may be more distantly related to other corona-
virus PLPD. In fact, the nucleotide sequences around the
IBV PLPD-1 recognition site are not compatible with
either alignment model proposed to explain the evolu-
tionary relationship among proteins of human coronavi-
rus 229E, mouse hepatitis virus, and transmissible gas-
troenteritis coronavirus (Herold et al., 1998). Finally, no
trans-cleavage activity has been detected so far for IBV
PLPD-1 either in cell-free translation systems or in intact
cells (unpublished observations). Once again, this is
markedly different from PLPD of both human coronavirus
and mouse hepatitis virus. It is therefore likely that IBV
PLPD-1 may be a unique member among the coronavi-
rus papain-like proteinase domains.
In a previous communication, we reported that a cel-
lular proteinase activity presented in Vero cell lysates
could mediate cleavage of in vitro synthesized ORF 1a
products at a position closed to the C-terminal cleavage
site of the 87-kDa protein (Liu et al., 1995). Subsequently,
we observed that the same cell lysate was able to
mediate cleavage of the 1a and 1a/1b polyproteins at
other positions (unpublished observations). However,
none of the cleavage products released from these po-
sitions corresponds to genuine mature cleavage prod-
ucts, if compared with products generated from virus-
infected or transfected cells. Cleavage at these positions
does not therefore reflect real cleavage events that oc-
curred in virus life cycles.
Deletion studies presented in this report clearly
showed that cleavage at the Gly673–Gly674 dipeptide
bond may be the only proteolytic event occurring in the
polyprotein encoded by the first 5753 bp of ORF 1a. This
cleavage led to the production of the N-terminal 87-kDa
and the C-terminal 160-kDa cleavage products. It was
intriguing to note that the 160-kDa protein can also be
efficiently immunoprecipitated by the N-terminal specific
antiserum V59 (see Fig. 2). We have also observed that
the 87-kDa protein can be coimmunoprecipitated by a
region-specific antiserum recognizing the IBV sequence
encoded between nucleotides 4868 and 5576 (unpub-
lished observations). The coimmunoprecipitation of the
160-kDa protein by antiserum V59 is likely due to the
interaction between the N- and C-terminal cleavage
products. Further investigation is underway to character-
ize this interaction.
MATERIALS AND METHODS
Transient expression of IBV sequences in Vero cells
using a vaccinia virus-T7 expression system
IBV sequences placed under the control of a T7
promoter were transiently expressed in eukaryotic
cells using the system described by Fuerst et al.,
(1986). Briefly, 60–80% confluent monolayers of Vero
cells grown on 35-mm dishes were infected with 10
PFU/cell of a recombinant vaccinia virus (vTF7-3)
which expresses bacteriophage T7 RNA polymerase.
The cells were then transfected with 2.5 mg plasmid
DNA (prepared with Qiagen plasmid Midi kits) by us-
ing DOSPER (or DOTAP) liposomal transfection re-
agent according to the instructions of the manufac-
turer (Boehringer Mannheim). As determined by mon-
itoring the expression of a reporter plasmid coding for
the green fluorescent protein from the jellyfish Ae-
quorea victoria, 25–35% of the transfection efficiency
was usually achieved by this procedure.
After incubation at 37°C for 5 h, the cells were washed
twice with methionine-free medium and were labeled
with 25 mCi/ml [35S]methionine. The radiolabeled cells
were harvested at 18 h postinfection.
Polymerase chain reaction (PCR)
Amplification reactions of the respective template
DNAs with appropriate primers were performed with
Pfu DNA polymerase (Stratagene) under standard
buffer conditions with 2 mM MgCl2. PCR reaction con-
ditions were 30 cycles of 95°C for 45 s, X°C for 45 s,
and 72°C for X min. The annealing temperature (X°C)
and the extension time (X min) were subjected to
adjustments according to the melting temperature of
the primers employed and the length of the PCR frag-
ments synthesized.
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Site-directed mutagenesis
Site-directed mutagenesis was carried out, as previ-
ously described, by two rounds of PCR with two pairs of
primers (Liu et al., 1997).
Radioimmunoprecipitation
Plasmid DNA-transfected Vero cells were lysed with
radioimmunoprecipitation assay buffer [50 mM Tris–HCl
(pH 7.5), 150 mM NaCl, 1% sodium deoxycholate, 1%
NP-40, 0.1% sodium dodecyl sulfate (SDS)] and pre-
cleared by centrifugation at 12,000 rpm for 5 min at 4°C
in a microfuge. Immunoprecipitation was performed as
described previously (Liu et al., 1991).
SDS–polyacrylamide gel electrophoresis
SDS–polyacrylamide gel electrophoresis (SDS–PAGE)
of viral polypeptides was performed with 10% polyacryl-
amide gels (Laemmli, 1970). The 35S-labeled polypep-
tides were detected by autoradiography of the dried gels.
Construction of plasmids
Plasmids pIBV1a1 and pIBV1a2 (formerly called
pKT1a1 and pKT1a2), which cover the IBV sequences
from nucleotides 362 to 4858 and from 362 to 5753,
respectively (Liu et al., 1995), were used to construct
pIBV1a2D1, pIBV1a2D3, pIBV1a2D4, pIBV1a2D5,
pIBV1a2D8, and pIBV1a2D9 (see Fig. 1).
Plasmid pIBV1a2D1, which covers the IBV sequence
from nucleotides 1311 to 5753 and contains an artificial
AUG initiation codon in an optimal context (ACCAUGG)
located immediately upstream of the viral sequence, was
constructed by cloning a BamHI/MluI-digested PCR frag-
ment into BglII/MluI-digested pIBV1a2 (Fig. 2a). BglII di-
gests pIBV1a2 at a position immediately upstream of the
viral sequence and MluI digests the IBV sequence at
nucleotide position 3997. The sequences of the upstream
primer (LDX-3) and downstream primer (LDX-4) used
were indicated in Table 1.
Plasmid pIBV1a2D3 was made by deletion of the IBV
sequence between nucleotides 2251 and 3832 from
pIBV1a2. This was achieved by digestion of pIBV1a2 with
NcoI, which cuts the IBV sequences at nucleotide posi-
tions 2251, 2642, and 3832, respectively, and religation
with T4 DNA ligase (Fig. 1).
Plasmid pIBV1a2D4 was constructed by cloning a
2685-bp BamHI/MluI-digested PCR fragment, containing
the IBV sequence from nucleotides 362 to 3047, into
BglII/MluI-digested pIBV1a2, resulting in the deletion of
the region between nucleotides 3047 and 3997. The
upstream and downstream primers used were LKP-1 and
LKP-2, respectively (Table 1).
Plasmid pIBV1a2D5, which covers the IBV sequence
from nucleotides 362 to 5027, was made as follows. A
1030-bp restriction fragment covering the IBV sequence
between nucleotides 3997 and 5027 was obtained by
digestion of pIBV1a2 sequentially with MluI and SpeI and
was then inserted into MluI/XbaI-digested pIBV1a1, giv-
ing rise to pIBV1a2D5. SpeI cuts the IBV sequence at
nucleotide position 5027, and XbaI digests pIBV1a1 at a
position 120 nucleotides downstream of the viral se-
quence presented in this plasmid.
Plasmid pIBV1a2D8, which contains a UAA stop codon
at nucleotide position 2854, was constructed by inserting
a BamHI/MluI-digested PCR fragment into BglII/MluI-
digested pIBV1a2. The sequences of the upstream
primer LKP-1 and downstream primer LKP-3 are shown
in Table 1. As can be seen, the UAA codon was intro-
duced by the downstream primer LKP-3. Plasmid
pIBV1a2D9, which covers the IBV sequence from nucle-
otides 1311 to 5753 and contains a UAA termination
codon at nucleotide position 2854, was constructed as
follows. A 1571-bp PCR fragment was generated with
pIBV1a2D8 as the template and LDX-3 and LKP-3 as
primers (Table 1). This PCR fragment was then digested
with BamHI and MluI and ligated into BglII- and MluI-
digested pIBV1a2, giving rise to pIBV1a2D9.
Plasmids pIBV1a2D10, pIBV1a2D11, and pIBV1a2D12,
which contain the IBV sequences starting from nucleo-
tide 1311 and ending at nucleotides 2598, 2544, and
2514, respectively, were constructed by cloning BamHI-
and SmaI-digested PCR fragments into BglII- and SmaI-
digested pKTO (Liu et al., 1994). The PCR fragments used
to construct these plasmids were generated with
pIBV1a2D1 as template and LDX-3 as the upstream
primer. The downstream primers used were LKP-4,
LKP-5, and LKP-6, respectively (Table 1). Again, a UAA
termination codon inserted immediately downstream of
TABLE 1
Oligonucleotides Used for PCR Amplification
and Site-Directed Mutagenesis
Name Nucleotide sequence Position
LDX-3 59-ACGCGGATCCACCATGGGTTCTAAG-39 1304–1323
LDX-4 59-TCTGTTTGCAAGTTACATCG-39 4060–4041
LKP-1 59-TCTCAGGGATCCCCCCACATACC-39 370–383
LKP-2 59-ACGCTAACGCGTTCATCAAGAGGCAG-39 3047–3022
LKP-3 59-CTCTCATAGACGCGTTAGATCAAATGGC-39 2870–2843
LKP-4 59-ATAGGCCCGGGTTAAGGTGGTGGTATCT-39 2612–2584
LKP-5 59-CAGTCCCGGGTTATGCTTTGCAAACCAC-39 2557–2530
LKP-6 59-CATTAATCCCGGGTTATTGAGACATTGGTG-39 2530–2501
LKP-7 59-CGATGGAAATAGCTGGATTAGTTCAGC-39 4338–4364
LKP-8 59-GAACTAATCCAGCTATTTCCATCGCG-39 4361–4336
LKP-9 59-CTAATAGTGGCAAGTGTTATACACAAGC-39 4826–4853
LKP-10 59-GTATAACACTTGCCACTATTAGTAGAAC-39 4847–4820
LKP-11 59-GTTTGCAAAGCAGCTGGTAAGACTGT-39 2533–2558
LKP-12 59-GTGACAGTCTTACCAGCTGCTTTGCA-39 2561–2537
LKP-13 59-GGTAAGAGCGTCACCTTTGGAGAAA-39 2548–2572
LKP-14 59-GGTGACGCTCTTACCGCCTGCTTTG-39 2562–2538
LKP-15 59-TTGCAAAGCAAAGACTGTCACCTTTG-39 2535–2560
LKP-16 59-AGGTGACAGTCTTTGCTTTGCAAACC-39 2532–2557
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the viral sequences in these constructs was introduced
by the downstream primers (see Fig. 1).
Two mutants, pIBV1a2D4C1274-S and pIBV1a2D4H1437-K,
with alterations at the putative catalytic residues Cys1274
and His1437, respectively, were created by PCR with
pIBV1a2D4 as templates. Plasmid pIBV1a2D4C1274-S con-
tains a substitution mutation of the Cys1274 residue to a Ser
and pIBV1a2D4H1437-K contains a mutation of the His1437
residue to a Lys. The pairs of primers used to introduce
these mutations were LKP-7/LKP-8 and LKP-9/LKP-10, re-
spectively (Table 1).
Similarly, plasmids pIBV1a2D4G673-A, pIBV1a2D4T676-S,
and pIBV1a2D4DG673-G674 were constructed by two rounds
of PCR based on plasmid pIBV1a2D4. Plasmid
pIBV1a2D4G673-A contains a substitution mutation of the
Gly673 residue to an Ala, and pIBV1a2D4T676-S contains a
mutation of the Thr676 residue to a Ser. The sequences of
the mutation primers, LKP-11/LKP-12 and LKP-13/LKP-14,
are shown in Table 1. Plasmid pIBV1a2D4DG673-G674 con-
tains a deletion of six nucleotides coding for Gly673 and
Gly674 residues. The pair of primers used was LKP–15/
LKP–16 (Table 1).
All the mutant constructs were selected and confirmed
by automated sequencing.
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